Company Data
Innoviva Inc.
Ticker
INVA
Current Price
$18.08 -0.77%
Market Cap
$1.1B
Price Target
Refer to Report
Volume
263.2K
52wk Range
$14.325 - $21.28
Overview
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance’s respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.